Gene Expression Profiles Reveal Altered Metabolic Signaling Pathway in Skeletal Muscle With Lipid Sensor Gpr120/Ffar4 Deficiency
Genes to Cells · 2026-05 · 31 (3)
DOI: 10.1111/gtc.70114 ↗Kurz gefasst
Fachartikel in der Zeitschrift Genes to Cells, online erschienen am 19.04.2026. Verfasst von Junfeng Shi und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan. Hauptthemen laut MEDLINE: Muscle, Skeletal, Signal Transduction, Receptors, G-Protein-Coupled, Transcriptome. Die Arbeit nennt 36 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.
Abstract (Originalsprache)
Obesity is driven by a chronic imbalance between energy intake and energy expenditure (EE), and reduced EE has been implicated in its development. We previously demonstrated that deficiency of Gpr120 / Ffar4 , a lipid sensor, led to decreased EE. Since skeletal muscle is a major contributor to EE, we investigated whether Gpr120 is involved in skeletal muscle energy metabolism. We generated gene expression profiles of skeletal muscle in WT mice and Gpr120 ‐deficient (KO) mice under a normal diet (ND) and a high fat diet (HFD) using microarray analysis and found that Gpr120 was associated with mitochondrial gene expression in response to HFD. We also discovered that the enrichment patterns of Gene Ontology (GO) terms in skeletal muscle of Gpr120 ‐deficient mice were common to those of genetically modified mouse models associated with Ampk, Pgc1α , and Errγ , suggesting that these signaling factors may be involved in Gpr120‐mediated signaling. Moreover, analyses including ChIP‐seq of Err γ , morphological evaluation of mitochondria by electron microscopy, and measurements of mtDNA content and muscle strength demonstrated that Gpr120 was involved in regulating mitochondrial structure, gene expression, and skeletal muscle function. Together, our findings suggest that Gpr120 regulates mitochondrial homeostasis and function in skeletal muscle, possibly through signaling from distant organs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Genomic Drug Discovery Science, Graduate School of Pharmaceutical Sciences, Kyoto University, Kyoto, Japan.
- Department of Pharmacology, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
- Department of Liberal Arts, Faculty of Medicine, Saitama Medical University, Saitama, Japan.
- Department of Pharmacology, Faculty of Medicine, Toho University, Tokyo, Japan.
ORCID-Profile: Akira Hirasawa
Förderung
- Japan Society for the Promotion of Science
Zitieren
APA
Shi, J., Nakayama, T., Iida, K., Shirai, R., Ueno, K., Hirata, A., Awaji, T., Maruyama, K., Kawamura, Y., Takei, Y., & Hirasawa, A. (2026). Gene Expression Profiles Reveal Altered Metabolic Signaling Pathway in Skeletal Muscle With Lipid Sensor Gpr120/Ffar4 Deficiency. Genes to Cells, 31(3). https://doi.org/10.1111/gtc.70114
Vancouver
Shi J, Nakayama T, Iida K, Shirai R, Ueno K, Hirata A, et al. Gene Expression Profiles Reveal Altered Metabolic Signaling Pathway in Skeletal Muscle With Lipid Sensor Gpr120/Ffar4 Deficiency. Genes to Cells. 2026;31(3). doi:10.1111/gtc.70114
BibTeX
@article{Shi2026,
author = {Shi, Junfeng and Nakayama, Taito and Iida, Keiko and Shirai, Ryohei and Ueno, Kenya and Hirata, Ayako and Awaji, Takeo and Maruyama, Kei and Kawamura, Yuuki and Takei, Yoshinori and Hirasawa, Akira},
title = {Gene Expression Profiles Reveal Altered Metabolic Signaling Pathway in Skeletal Muscle With Lipid Sensor Gpr120/Ffar4 Deficiency},
journal = {Genes to Cells},
year = {2026},
volume = {31},
number = {3},
doi = {10.1111/gtc.70114}
}
EUVIMED